✦ LIBER ✦

Efficacy of penicillin treatment in purulent maxillary sinusitis. A European multicenter trial

✍ Scribed by C. E. Nord

Publisher: Springer-Verlag
Year: 1988
Tongue: English
Weight: 1000 KB
Volume: 16
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01650753

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of pramipe

Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: Results from a European multicenter trial

✍ J. Carsten Möller; Wolfgang H. Oertel; Jürgen Köster; Gianni Pezzoli; Leandro Pr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

## Abstract A double‐blind, placebo‐controlled study with a subsequent open‐label phase was conducted in 354 patients with Parkinson's disease (PD) and motor fluctuations under individually adjusted therapy with levodopa. During the double‐blind phase 174 patients received pramipexole and 180 place

BsmI vitamin D receptor genotypes influe

BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial

✍ Stefano Palomba; Francesco Orio; Tiziana Russo; Angela Falbo; Achille Tolino; Fr 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 361 KB

European multicenter field trial on the

European multicenter field trial on the efficacy and safety of a topical formulation of imidacloprid and permethrin (AdvantixTM) in dogs naturally infested with ticks and/or fleas

✍ K. Hellmann; T. Knoppe; K. Krieger; D. Stanneck 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 332 KB

Efficacy and safety of rebamipide for th

Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren’s syndrome: a double-blind placebo-controlled multicenter trial

✍ Susumu Sugai; Hiroki Takahashi; Shuji Ohta; Makoto Nishinarita; Masami Takei; Sh 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 413 KB

Doxorubicin-paclitaxel : A safe regimen

Doxorubicin-paclitaxel : A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trial

✍ Laura Biganzoli; Tanja Cufer; Peter Bruning; Robert E. Coleman; Luc Duchateau; B 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## BACKGROUND The potential cardiotoxicy of the doxorubicin‐paclitaxel regimen, when paclitaxel is given shortly after the end of the anthracycline infusion, is an issue of concern, as suggested by small single institution Phase II studies. ## METHODS In a large multicenter Phase III

Better efficacy of a 12-month interferon

Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial

✍ Jean-Louis Payen; Jacques Izopet; Virginie Galindo-Migeot; Valérie Lauwers-Cance 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB 👁 2 views

We studied the efficacy of three interferon alfa-2b (IFN-2b) regimens for the retreatment of patients with chronic hepatitis C (CHC) with prior complete response followed by relapse. Consecutive patients with CHC who had a complete biochemical response but relapse after a first course of 6 months of